Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells
Guo Qiang Chen
, Xue Geng Shi
, Wei Tang
, Shu Min Xiong
, Jun Zhu
, Xun Cai
, Ze Guang Man
, Jian Hua Ni
, Gui Ying Shi
, Pei Ming Jia
, Meng Min Liu
, Kai Li He
, Chao Niu
, Jun Ma
, Peng Zhang
, Ting Dong Zhang
, Pascale Paul
, Tomoki Naoe
, Kunio Kitamura
, Wilson Miller
Samuel Waxman, Zhen Yi Wang, Hugues De The, Sai Juan Chen, Zhu Chen
Research output: Contribution to journal › Article › peer-review
822Scopus
citations
Fingerprint
Dive into the research topics of 'Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells'. Together they form a unique fingerprint.